- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05657132
Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication
Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication in Necrotic Primary Molars, a Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The children were randomly divided into two groups (I, II) Group I (N=12): using Costus-based paste as an intracanal medicament. Group II (N= 12): Calcium hydroxide iodoform paste (Metapex) as an intracanal medicament.
Procedure:
Access opening was started. then a swab was taken from the distal root canal with a dry paper point and transferred to a sterile test tube. The canals were filled with an intracanal medication according to the patient group. In group I, the canals was filled with a previously prepared Costus-based paste for one week, and In Group II, the canals were filled with Meta paste for one week. After 1 week, the paste was washed away from the canals then another swab was taken from the distal canal by a dry paper point as done before preoperatively.
The 2 swabs were transferred within 2 hours to the lab for bacterial culture and detection of enterococcus faecalis count.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Ghada Salem, Ph.D
- Phone Number: +201005144561
- Email: ghadamohamedalirana@hotmail.com
Study Contact Backup
- Name: Mariem Elmansy
- Phone Number: 01223355029
- Email: drmaryamelmansy@hotmail.com
Study Locations
-
-
Bani Suif
-
Cairo, Bani Suif, Egypt
- Recruiting
- NUB University
-
Contact:
- Ghada Salem, Ph.D
- Phone Number: +201005144561
- Email: ghadamohamedalirana@hotmail.com
-
Contact:
- Mariem Elmansy
- Phone Number: 01223355029
- Email: drmaryamelmansy@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with clinically and radiologically diagnosed infected primary teeth in their mandibular arch.
- Teeth should be deeply carious, with a history of spontaneous pain and carious exposures with necrotic pulp was also be selected
- radiographic evidence of adequate alveolar bone support, and absence of internal or external resorption.
- tooth must be restorable.
Exclusion Criteria:
- vital tooth
- Non restorable teeth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Costus paste
Costus paste used as an intracanal medication for decreasing the number of enterococcus faecalis present in the necrotic root of the primary molar
|
study the effect of costus herbal paste on enterococcus faecalis bacteria
Other Names:
|
|
Active Comparator: metapaste
metapaste used as an intracanal medication for decreasing the number of enterococcus faecalis present in the necrotic root of the primary molar
|
compare the effect of Costus paste with meta paste in reducing the number of enterococcus faecalis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bacterial count
Time Frame: 1 weak
|
Colony forming unit
|
1 weak
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ghada Salem, Ph.D, associate professor of Pediatric Dentistry
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 050622
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infection Primary
-
Ayub Teaching HospitalCompletedPeritonitis | Primary Closure | Delayed Primary ClosurePakistan
-
Parc de Salut MarCompletedInfection After Primary Total Knee ArthroplastySpain
-
University of ZurichUnknownTreatment Efficacy | Monotherapy | Dolutegravir | Primary HIV InfectionSwitzerland
-
Zealand University HospitalEnrolling by invitationPleural Diseases | Pleural Effusion | Pleural Infection | Pneumothorax Spontaneous Secondary | Pneumothorax Spontaneous PrimaryDenmark
-
University Hospital, MontpellierRecruitingSevere Infection | Severe Immune DeficiencyFrance
-
Mikrobiomik Healthcare Company S.L.CompletedRecurrent Clostridium Difficile Infection | Primary Clostridium Difficile InfectionSpain
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Not yet recruitingLower Respiratory Tract Infection | Primary Health Care
-
New York Medical CollegeJohns Hopkins University; Children's Hospital of Philadelphia; Medical College... and other collaboratorsRecruitingPrimary Immune Deficiency Disorder | Viral InfectionUnited States
-
University Hospital, MontpellierRecruitingPrimary ImmunodeficiencyFrance
-
University of MichiganNational Institute of Mental Health (NIMH); Emory University; University of California... and other collaboratorsTerminatedHIV Infections | HIV Primary InfectionUnited States
Clinical Trials on herbal intracanal medication paste
-
Ege UniversityHealth Institutes of TurkeyActive, not recruitingApical Periodontitis | Post Operative Pain | Intracanal Medicament | Root Canal TreatmentTurkey (Türkiye)
-
Ankara UniversityRecruitingPostoperative Pain | Root Canal Retreatment | Calcium Hydroxide | Medicaments Substances in Therapeutic UseTurkey (Türkiye)
-
Mansoura UniversityRecruiting
-
Future University in EgyptActive, not recruiting
-
Cairo UniversityNot yet recruitingBiomarkers | Apical Periodontitis | Calcium Hydroxide | Intracanal Dressing | Inflammatory Mediators
-
Hadeer Maher Mostafa MohamedRecruitingEndodontically Retard Teeth | Periapical RadiolucencyEgypt
-
Al-Azhar UniversityRecruitingPrevious Endodontic Treatment Failure and Radiographically Confirmed Periapical RadiolucencyEgypt
-
Mahy Abdel Raouf Aly KamarNot yet recruitingApical Periodontitis | Necrotic Primary Molars | Periapical Pathosis of Primary Molars
-
Suez Canal UniversityUniversity of LeedsActive, not recruitingAsymptomatic Apical PeriodontitisEgypt
-
Minia UniversityNot yet recruitingPostoperative Pain | Diabete Type 2 | Flare up | Flare Up, Symptom